PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22421369-1	2012	ZRBA1 is a quinazoline-based molecule termed "combi-molecule" designed to block the epidermal growth factor receptor (EGFR) and further degrade to FD105, an EGFR inhibitor plus a DNA-alkylating agent.	Quinazolines	11-22	epidermal growth factor receptor	Homo sapiens	84-116	
22421369-1	2012	ZRBA1 is a quinazoline-based molecule termed "combi-molecule" designed to block the epidermal growth factor receptor (EGFR) and further degrade to FD105, an EGFR inhibitor plus a DNA-alkylating agent.	Quinazolines	11-22	epidermal growth factor receptor	Homo sapiens	118-122	
22421369-1	2012	ZRBA1 is a quinazoline-based molecule termed "combi-molecule" designed to block the epidermal growth factor receptor (EGFR) and further degrade to FD105, an EGFR inhibitor plus a DNA-alkylating agent.	Quinazolines	11-22	epidermal growth factor receptor	Homo sapiens	157-161	
22421369-9	2012	This study conclusively demonstrated that designing molecules as prodrugs of high levels of quinazoline inhibitors of EGFR and bifunctional DNA cross-linking species is a valid strategy to enhance the potency of mixed EGFR-DNA-targeting combi-molecules.	Quinazolines	92-103	epidermal growth factor receptor	Homo sapiens	118-122	
22421369-9	2012	This study conclusively demonstrated that designing molecules as prodrugs of high levels of quinazoline inhibitors of EGFR and bifunctional DNA cross-linking species is a valid strategy to enhance the potency of mixed EGFR-DNA-targeting combi-molecules.	Quinazolines	92-103	epidermal growth factor receptor	Homo sapiens	218-222